EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca2+ channel

Dragos Andrei Duse, Nathalie Hannelore Schröder, Tanu Srivastava, Marcel Benkhoff, Jens Vogt, Melissa Kim Nowak, Florian Funk, Nina Semleit, Philipp Wollnitzke, Ralf Erkens, Sebastian Kötter, Sven Günther Meuth und 7 weitere

Basic Research in Cardiology · 2024

DOI: 10.1007/s00395-024-01073-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Basic Research in Cardiology, 2024. Verfasst von Dragos Andrei Duse und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Medicine III, University Hospital Düsseldorf and Heinrich Heine University, Düsseldorf, Germany. Hauptthemen laut MEDLINE: Calcium Channels, L-Type, Hypertension, Ventricular Remodeling, Mice, Knockout. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Faculty of the Heinrich Heine University, Deutsche Forschungsgemeinschaft, Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The erythrocyte S1P transporter Mfsd2b is also expressed in the heart. We hypothesized that S1P transport by Mfsd2b is involved in cardiac function. Hypertension-induced cardiac remodeling was induced by 4-weeks Angiotensin II (AngII) administration and assessed by echocardiography. Ca 2+ transients and sarcomere shortening were examined in adult cardiomyocytes (ACM) from Mfsd2b +/+ and Mfsd2b −/− mice. Tension and force development were measured in skinned cardiac fibers. Myocardial gene expression was determined by real-time PCR, Protein Phosphatase 2A (PP2A) by enzymatic assay, and S1P by LC/MS, respectively. Msfd2b was expressed in the murine and human heart, and its deficiency led to higher cardiac S1P. Mfsd2b −/− mice had regular basal cardiac function but were protected against AngII-induced deterioration of left-ventricular function as evidenced by ~ 30% better stroke volume and cardiac index, and preserved ejection fraction despite similar increases in blood pressure. Mfsd2b −/− ACM exhibited attenuated Ca 2+ mobilization in response to isoprenaline whereas contractility was unchanged. Mfsd2b −/− ACM showed no changes in proteins responsible for Ca 2+ homeostasis, and skinned cardiac fibers exhibited reduced passive tension generation with preserved contractility. Verapamil abolished the differences in Ca 2+ mobilization between Mfsd2b +/+ and Mfsd2b −/− ACM suggesting that S1P inhibits L-type-Ca 2+ channels (LTCC). In agreement, intracellular S1P activated the inhibitory LTCC phosphatase PP2A in ACM and PP2A activity was increased in Mfsd2b −/− hearts. We suggest that myocardial S1P protects from hypertension-induced left-ventricular remodeling by inhibiting LTCC through PP2A activation. Pharmacologic inhibition of Mfsd2b may thus offer a novel approach to heart failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium Channels, L-TypeHypertensionVentricular RemodelingMice, KnockoutSphingosineMyocytes, CardiacLysophospholipidsAnimalsHumansMice, Inbred C57BLMiceMaleDisease Models, AnimalMyocardial ContractionVentricular Function, LeftAngiotensin IIProtein Phosphatase 2

Stichwörter der Autor:innen

CardioprotectionLeft-ventricular remodelingMfsd2bSphingosine-1-phosphate

Substanzen

Calcium Channels, L-TypeSphingosineLysophospholipidssphingosine 1-phosphateAngiotensin IIProtein Phosphatase 2

Autor:innen und Institutionen

  • Institute for Molecular Medicine III, University Hospital Düsseldorf and Heinrich Heine University, Düsseldorf, Germany.
  • Department of Cardiology, Pneumology, and Vascular Medicine, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Cardiovascular Research Institute Düsseldorf (CARID), Düsseldorf, Germany.
  • Institute of Pharmacology, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Institute of Cardiovascular Physiology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Department of Neurology, Medical Faculty, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.

Förderung

  • Medical Faculty of the Heinrich Heine University
  • Deutsche Forschungsgemeinschaft
  • Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts

Zitieren

APA

Duse, D. A., Schröder, N. H., Srivastava, T., Benkhoff, M., Vogt, J., Nowak, M. K., Funk, F., Semleit, N., Wollnitzke, P., Erkens, R., Kötter, S., Meuth, S. G., Keul, P., Santos, W., Polzin, A., Kelm, M., Krüger, M., Schmitt, J., & Levkau, B. (2024). Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca2+ channel. Basic Research in Cardiology. https://doi.org/10.1007/s00395-024-01073-x

Vancouver

Duse DA, Schröder NH, Srivastava T, Benkhoff M, Vogt J, Nowak MK, et al. Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca2+ channel. Basic Research in Cardiology. 2024. doi:10.1007/s00395-024-01073-x

BibTeX
@article{Duse2024,
  author = {Duse, Dragos Andrei and Schröder, Nathalie Hannelore and Srivastava, Tanu and Benkhoff, Marcel and Vogt, Jens and Nowak, Melissa Kim and Funk, Florian and Semleit, Nina and Wollnitzke, Philipp and Erkens, Ralf and Kötter, Sebastian and Meuth, Sven Günther and Keul, Petra and Santos, Webster and Polzin, Amin and Kelm, Malte and Krüger, Martina and Schmitt, Joachim and Levkau, Bodo},
  title = {Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca2+ channel},
  journal = {Basic Research in Cardiology},
  year = {2024},
  doi = {10.1007/s00395-024-01073-x}
}
Kostenlos starten →